Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance

Antimicrobial resistance (AMR) is a major public health problem threatening to reverse the progress made against infectious diseases. The rapid increase of AMR exposes Italian hospitals at increased risk of untreatable infections. Vaccinations can potentially limit AMR by reducing the number of infe...

Full description

Bibliographic Details
Main Authors: Federico Marchetti, Rosa Prato, Pierluigi Viale
Format: Article
Language:English
Published: Taylor & Francis Group 2021-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2021.1969853
_version_ 1797673335732043776
author Federico Marchetti
Rosa Prato
Pierluigi Viale
author_facet Federico Marchetti
Rosa Prato
Pierluigi Viale
author_sort Federico Marchetti
collection DOAJ
description Antimicrobial resistance (AMR) is a major public health problem threatening to reverse the progress made against infectious diseases. The rapid increase of AMR exposes Italian hospitals at increased risk of untreatable infections. Vaccinations can potentially limit AMR by reducing the number of infected cases in need of antibiotics. We conducted a survey among Italian vaccine experts to record their opinion regarding the role of vaccinations against antibiotic resistance (ABR). Among 80 invited experts, 51 answered all questions. Most respondents were experts in hygiene and preventive medicine (56.9%) and aged >50 years (72.6%). ABR was a priority concern in the daily professional activity of 82.4% of respondents. Overall, 47.1% of respondents believed that all vaccinations included in the vaccination calendar played a role against ABR: 92.2% for pertussis vaccination followed by 88.2%, 74.5%, and 70.6% for meningococcus, measles, and varicella vaccinations, respectively. Almost all respondents agreed that the role of vaccinations against ABR should be clearly expressed in the national vaccination guidelines (96.1%) and Scientific Societies should take an explicit position on the issue (92.2%). These results show that Italian experts have recognized the vaccinations’ potential role in limiting ABR and guidelines from the appropriate scientific and governmental authorities are needed.
first_indexed 2024-03-11T21:43:04Z
format Article
id doaj.art-cedeff0444594754966744bb612f274a
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T21:43:04Z
publishDate 2021-11-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-cedeff0444594754966744bb612f274a2023-09-26T12:43:41ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2021-11-0117114283429010.1080/21645515.2021.19698531969853Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistanceFederico Marchetti0Rosa Prato1Pierluigi Viale2GSKUniversity of FoggiaUniversity of BolognaAntimicrobial resistance (AMR) is a major public health problem threatening to reverse the progress made against infectious diseases. The rapid increase of AMR exposes Italian hospitals at increased risk of untreatable infections. Vaccinations can potentially limit AMR by reducing the number of infected cases in need of antibiotics. We conducted a survey among Italian vaccine experts to record their opinion regarding the role of vaccinations against antibiotic resistance (ABR). Among 80 invited experts, 51 answered all questions. Most respondents were experts in hygiene and preventive medicine (56.9%) and aged >50 years (72.6%). ABR was a priority concern in the daily professional activity of 82.4% of respondents. Overall, 47.1% of respondents believed that all vaccinations included in the vaccination calendar played a role against ABR: 92.2% for pertussis vaccination followed by 88.2%, 74.5%, and 70.6% for meningococcus, measles, and varicella vaccinations, respectively. Almost all respondents agreed that the role of vaccinations against ABR should be clearly expressed in the national vaccination guidelines (96.1%) and Scientific Societies should take an explicit position on the issue (92.2%). These results show that Italian experts have recognized the vaccinations’ potential role in limiting ABR and guidelines from the appropriate scientific and governmental authorities are needed.http://dx.doi.org/10.1080/21645515.2021.1969853antibiotic resistanceitalymeaslesmenacwymenbmeningococcalvaccinationvaccinesvaricellapertussis
spellingShingle Federico Marchetti
Rosa Prato
Pierluigi Viale
Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
Human Vaccines & Immunotherapeutics
antibiotic resistance
italy
measles
menacwy
menb
meningococcal
vaccination
vaccines
varicella
pertussis
title Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
title_full Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
title_fullStr Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
title_full_unstemmed Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
title_short Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
title_sort survey among italian experts on existing vaccines role in limiting antibiotic resistance
topic antibiotic resistance
italy
measles
menacwy
menb
meningococcal
vaccination
vaccines
varicella
pertussis
url http://dx.doi.org/10.1080/21645515.2021.1969853
work_keys_str_mv AT federicomarchetti surveyamongitalianexpertsonexistingvaccinesroleinlimitingantibioticresistance
AT rosaprato surveyamongitalianexpertsonexistingvaccinesroleinlimitingantibioticresistance
AT pierluigiviale surveyamongitalianexpertsonexistingvaccinesroleinlimitingantibioticresistance